Couldn’t find anything that definitively says SB doesn’t cross blood barrier, but it’s a derivative of glycopyrrolate (which some say doesn’t, some say ‘minimal’) with less CNS side effects so I guess that’s good for us. What were your thoughts?
Couldn’t find anything that definitively says SB doesn’t cross...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
-0.005(1.33%) |
Mkt cap ! $678.7M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.0¢ | 36.5¢ | $582.0K | 1.562M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 505501 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 290743 | 9 |
View Market Depth
| Last trade - 10.35am 30/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |